Navigation Links
Liver disease: Understanding it will enable the provision of better treatment
Date:4/18/2013

In this prospective study, led by Dr Richard Moreau, INSERM Research Director (Mixed Research Unit 773 "Centre de Recherche biomdicale Bichat-Beaujon"; INSERM/Universit Paris Diderot) who is also a practitioner attached to the Hepatology Department of the Beaujon Hospital (AP-HP), researchers studied a cohort of 1343 patients from 12 European countries.

The results, published in the learned journal Gastroenterology, describe, for the first time, the specific profile of sufferers from this syndrome that is associated with cirrhosis. This also makes it possible to more clearly define the actual rules of attribution of the organs in those most severely affected, for whom there is a high risk of early death.

Cirrhosis is an irreversible liver disease. It is characterised by chronic inflammation that destroys the liver cells and produces anarchic regeneration in the form of nodules. The disease causes the liver to lose function and is accompanied by multiple complications. When these complications manifest (bleeding in the digestive tract, bacterial infection, accumulation of liquid in the abdomen, etc.), this is known as decompensated cirrhosis and the patients are hospitalised.

A certain number of these patients quickly develop a syndrome characterised by acute liver failure and/or failure of other vital organs1 (ACLF acute-on-chronic liver failure). The syndrome is associated with a high risk of death at one month and no diagnostic criteria were clearly established hitherto that might make it possible to describe the condition.

Through a consortium , the researchers in Mixed Research Unit 773 "Centre de Recherche biomdicale Bichat-Beaujon" (INSERM/Universit Paris Diderot), analysed data from 1343 patients hospitalised due to acute cirrhosis complications between February and September 2011 in 29 Hepatology Departments in 12

European countries . This enabled them to define robust diagnostic criteria for ACLF, indicating that one-third of the patients enrolled in the study had developed this syndrome.

The researchers noted that, compared to patients not suffering from ACLF, those who developed acute failure of an organ or organs were younger, were most frequently prey to alcoholism, suffered from a larger number of bacterial infections and had higher levels of white blood cells, as well as other markers of organ inflammation.

Quite unexpectedly, failure was most severe in patients without a previous history of cirrhosis complications. A high number of organ malfunctions (liver, kidneys, brain) were observed in these patients, including white blood cells in the blood and a mortality rate within one month of admission to hospital that was15 times greater than in patients who had a previous history.

"The identification of the criteria to define acute failure of an organ or organs enabled us to show that this is a separate syndrome from cirrhosis complications. In addition to organ failure and the high associated mortality, the development of the disease depends on the patient's age and medical history", explains Richard Moreau, INSERM Director of Research, and the Principal Investigator for the study. "We hope to be able to better identify those at risk of early death in order to improve their treatment. Furthermore, these results could lead to improving the current rules for assigning organs for grafting in the severest cases", he concludes.


'/>"/>

Contact: Richard Moreau
Richard.moreau@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related medicine news :

1. New ablation technique holds promise for liver cancer patients
2. April is IBS Awareness Month with Digestive & Liver Disease Center of San Antonio
3. Scarring May Raise Death Risk From Fatty Liver Disease
4. Polymer platform technology innovates drug delivery
5. ReviMedia Partners with RingRevenue to Deliver a Comprehensive Lead Generation Solution
6. The Signature Group, Inc. Partners with Alert Logic to Deliver Security and Compliance Solutions
7. SierraCRM Delivers Major Enhancements to the Process Manager Workflow Module for Sugar.
8. Fatty Liver Treatment
9. How “Fatty Liver Diet Guide” Helps People Treat Fatty Liver Quickly – Vkool.com
10. Liver transplantation for patients with genetic liver conditions has high survival rate
11. Incarceration, marijuana use and suicide attempts may hinder liver transplant eligibility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... CA (PRWEB) , ... August 21, 2017 , ... The ... how exactly are we supposed to get things done in a healthy way these ... And, they’re launching a crowdfunding campaign on August 28 to introduce Deskcise Pro™– the ...
(Date:8/21/2017)... ... 2017 , ... The American Hospital Association (AHA) has elected Claire Zangerle, Chief ... its Board of Trustees for a three-year term beginning January 1, 2018. , ... individuals that are committed to the improvement of health in their communities. Founded in ...
(Date:8/21/2017)... Los Angeles, CA (PRWEB) , ... August 21, ... ... Optum, the health services business of UnitedHealth Group (NYSE: UNH), has made a ... and first responders affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries ...
(Date:8/20/2017)... ... ... A total solar eclipse will occur across the U.S. on Monday, August 21, ... the sun and Earth. This rare event will be magnificent to witness, but what does ... on the road during the total eclipse of the sun. , 1. Plan ahead. The ...
(Date:8/20/2017)... ... ... State Farm Neighborhood Assist® has named The Southern Maryland Team Anti-Bullying Program ... initiative wins, Gals Lead – Dream Queen Foundation’s signature teen girl program to help ... Calvert and Charles Counties. The program could potentially impact nearly 17,500 female students (49.4 ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- Axium Pharmaceuticals Inc., the creator of the drug Truveta for ... of an IPO. The United States ... of a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... staggering figure is the fact that Americans spent $42 billion on anxiety ...
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/11/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it will release its second quarter ... conference call at 9:00am ET. The Company will discuss ... its strategy and outlook for the remainder of 2017. The ... , Chief Executive Officer, and Zvi Ben-David , ...
Breaking Medicine Technology: